IL162864A - Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol - Google Patents

Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol

Info

Publication number
IL162864A
IL162864A IL16286498A IL16286498A IL162864A IL 162864 A IL162864 A IL 162864A IL 16286498 A IL16286498 A IL 16286498A IL 16286498 A IL16286498 A IL 16286498A IL 162864 A IL162864 A IL 162864A
Authority
IL
Israel
Prior art keywords
formoterol
inhalation
formulation
bulk density
poured bulk
Prior art date
Application number
IL16286498A
Inventor
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9700134A external-priority patent/SE9700134D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL162864A publication Critical patent/IL162864A/en

Links

IL16286498A 1997-01-20 1998-01-13 Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol IL162864A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700134A SE9700134D0 (en) 1997-01-20 1997-01-20 New formulation
IL13083798A IL130837A0 (en) 1997-01-20 1998-01-13 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising formoterol

Publications (1)

Publication Number Publication Date
IL162864A true IL162864A (en) 2005-03-20

Family

ID=34575784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16286498A IL162864A (en) 1997-01-20 1998-01-13 Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol

Country Status (1)

Country Link
IL (1) IL162864A (en)

Similar Documents

Publication Publication Date Title
SI1007017T2 (en) Budesonide/formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
HUP0000843A3 (en) New formulation for inhalation having a poured bulnew formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising fok density of from 0,28 to 0,38 g/ml, comprising formoterol rmoterol
HK1009405A1 (en) Metered dose inhaler for salmeterol.
ZA997733B (en) Hydrazide compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0000841A3 (en) New formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising budesonide and process for its preparation
IL112227A0 (en) Compounds, their preparation and pesticidal compositions containing them
IL123648A0 (en) 1,4-Benzothiazepine-1,1-dioxides their preparation and pharmaceutical compositions containing them
ZA200001159B (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
HUP0000755A3 (en) New formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
HU9502200D0 (en) Insecticidal n-substituted-n'(optionally substituted)-n-n'-diacylhidrazines
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
IL162864A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol
SI1009394T1 (en) New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol
ZA200007646B (en) Inhalation of aerosol actives.
HUP9803017A3 (en) Benzofuryl and benzothienyl compounds a process for producing them and pharmaceutical compositions containing them
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
GR3019681T3 (en) 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments.
HU9802620D0 (en) 1,4-diaryl-2,3-difluoro-2-butene-derivatives, process for their preparation, insecticidal and acaricidal agents
SG33434A1 (en) Pharmaceutical preparation containing estra-1,3,5(10)-triene-derivatives
ZA983924B (en) Pesticide compounds compositions and process for the preparation thereof
SI0820323T1 (en) Metered dose inhaler for salmeterol
ZA958167B (en) 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds a process for the preparation thereof a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments
AU8086098A (en) Delta 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired